We are live on ! Find out more
TDC

Thompson Davis & Co Portfolio holdings

AUM $150M
1-Year Est. Return 32.35%
This Fund
S&P 500
This Quarter Est. Return
+11.83%
1 Year Est. Return
+32.35%
3 Year Est. Return
+199.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$42.2M
AUM Growth
-$14.3M
Cap. Flow
-$17.4M
Cap. Flow %
-41.13%
Top 10 Hldgs %
21.94%
Holding
1,277
New
146
Increased
131
Reduced
218
Closed
593

Top Buys

Rank Stock Value
1
VBR icon
Vanguard Small-Cap Value ETF
VBR
+$601K
2
KNSL icon
Kinsale Capital Group
KNSL
+$335K
3
PXLW icon
Pixelworks
PXLW
+$273K
4
GM icon
General Motors
GM
+$255K
5
MITL
Mitel Networks Corporation
MITL
+$250K

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$623K
2
INTC icon
Intel
INTC
+$608K
3
BAC icon
Bank of America
BAC
+$558K
4
AAPL icon
Apple
AAPL
+$527K
5
FDC
First Data Corporation
FDC
+$384K

Sector Composition

Rank Sector Weight
1 Technology 18.91%
2 Financials 9.93%
3 Healthcare 9.91%
4 Industrials 9.33%
5 Consumer Discretionary 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPOR
651
DELISTED
Gulfport Energy Corp.
GPOR
$1K ﹤0.01%
116
-24,779
-100% -$330K
CHK
652
DELISTED
Chesapeake Energy Corporation
CHK
$1K ﹤0.01%
1
– –
JCP
653
DELISTED
J.C. Penney Company, Inc.
JCP
$1K ﹤0.01%
200
– –
ALDR
654
DELISTED
Alder Biopharmaceuticals
ALDR
$1K ﹤0.01%
125
-250
-67% -$2.79K
ADOM
655
DELISTED
ADOMANI Inc
ADOM
$1K ﹤0.01%
125
– –
IMDZ
656
DELISTED
Immune Design Corp.
IMDZ
$1K ﹤0.01%
250
– –
AAP icon
657
Advance Auto Parts
AAP
$3.37B
– –
-27
Closed -$3K
ABBV icon
658
AbbVie
ABBV
$458B
– –
-57
Closed -$5K
ABEV icon
659
Ambev
ABEV
$47.3B
– –
-224
Closed -$1K
ACHC icon
660
Acadia Healthcare
ACHC
$3.17B
– –
-207
Closed -$10K
ACN icon
661
Accenture
ACN
$89.9B
– –
-190
Closed -$26K
ACTG icon
662
Acacia Research
ACTG
$450M
– –
-35,350
Closed -$161K
ADM icon
663
Archer Daniels Midland
ADM
$41.4B
– –
-28
Closed -$1K
ADNT icon
664
Adient
ADNT
$1.6B
– –
-34
Closed -$3K
ADSK icon
665
Autodesk
ADSK
$44.3B
– –
-187
Closed -$21K
ADTN icon
666
Adtran
ADTN
$798M
– –
-6,525
Closed -$157K
AEE icon
667
Ameren
AEE
$31.5B
– –
-377
Closed -$22K
AEG icon
668
Aegon
AEG
$13.5B
– –
-2,699
Closed -$13K
AEIS icon
669
Advanced Energy
AEIS
$12.2B
– –
-790
Closed -$64K
AES icon
670
AES
AES
$10.6B
– –
-20,196
Closed -$223K
AIG icon
671
American International
AIG
$41.9B
– –
-195
Closed -$12K
AIN icon
672
Albany International
AIN
$2.14B
– –
-457
Closed -$26K
AIV
673
Aimco
AIV
$380M
– –
-908
Closed -$5K
AJG icon
674
Arthur J. Gallagher & Co
AJG
$63.7B
– –
-58
Closed -$4K
AKAM icon
675
Akamai
AKAM
$16.8B
– –
-462
Closed -$23K
25 26
27
28 29

Similar funds

PAYA
Phil A. Younker & Associates Fairbanks, Alaska $150M AUM 9.85% 1-Year Est. Return
PCMNC
Piedmont Capital Management (North Carolina) Greensboro, North Carolina $150M AUM
LA
Lakeside Advisors Seattle, Washington $150M AUM 14.73% 1-Year Est. Return
MPW
Magnolia Private Wealth Philadelphia, Pennsylvania $150M AUM 18.29% 1-Year Est. Return
GWA
Genesis Wealth Advisors Braintree, Massachusetts $150M AUM 15.35% 1-Year Est. Return
GA
Gordian Advisors Tucson, Arizona $150M AUM 15.35% 1-Year Est. Return
RPA
Redwood Park Advisors Redwood City, California $150M AUM 11.34% 1-Year Est. Return
E
Evansbrook Bolingbrook, Illinois $150M AUM

Thompson Davis & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Thompson Davis & Co held 1,277 positions worth $42.2M, down 25% from $56.5M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Thompson Davis & Co withdrew a net $17.4M in Q4 2017, closing 593 positions and reducing 218 holdings. Its most notable exit was Antares Pharma, Inc., an estimated $365K position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Thompson Davis & Co opened a new position in General Motors worth $241K.

  • Thompson Davis & Co's largest Q4 2017 buy was General Motors: 5,878 shares worth $241K.
  • Thompson Davis & Co added most to Vanguard Small-Cap Value ETF in Q4 2017, an estimated $601K increase.
  • Thompson Davis & Co's biggest Q4 2017 reduction was JPMorgan Chase, cutting an estimated $623K.
  • Thompson Davis & Co fully exited Antares Pharma, Inc. in Q4 2017, selling an estimated $365K.
  • Thompson Davis & Co's ten largest holdings make up 22% of its $42.2M portfolio in Q4 2017.
  • Thompson Davis & Co opened 146 new positions and closed 593 in Q4 2017.
  • Thompson Davis & Co's portfolio value fell 25% quarter-over-quarter to $42.2M.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.